Nisa Investment Advisors, LLC Nektar Therapeutics Transaction History

Nisa Investment Advisors, LLC

  • $16.7 Billion
  • Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 317 shares of NKTR stock, worth $326. This represents 0.0% of its overall portfolio holdings.

Number of Shares
317
Holding current value
$326
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$1.11 - $1.48 $351 - $469
317 New
317 $0
Q1 2023

May 02, 2023
BUY
$0.64 - $3.15 $9,158 - $45,076
14,310 Added 130.09%
25,310 $18,000
Q4 2022

Feb 02, 2023
SELL
$2.03 - $4.28 $408 - $860
-201 Reduced 1.79%
11,000 $25,000
Q3 2022

Nov 07, 2022
SELL
$3.04 - $5.14 $2,857 - $4,831
-940 Reduced 7.74%
11,201 $36,000
Q2 2022

Aug 03, 2022
BUY
$3.17 - $6.17 $34,870 - $67,870
11,000 Added 964.07%
12,141 $46,000
Q1 2022

Apr 29, 2022
SELL
$4.16 - $13.72 $69,322 - $228,630
-16,664 Reduced 93.59%
1,141 $6,000
Q4 2021

Feb 03, 2022
BUY
$10.83 - $18.41 $7,884 - $13,402
728 Added 4.26%
17,805 $198,000
Q3 2021

Oct 18, 2021
SELL
$13.07 - $18.84 $191,083 - $275,440
-14,620 Reduced 46.12%
17,077 $307,000
Q2 2021

Aug 06, 2021
SELL
$16.52 - $20.4 $137,116 - $169,320
-8,300 Reduced 20.75%
31,697 $544,000
Q1 2021

Apr 26, 2021
BUY
$16.56 - $25.46 $99,359 - $152,760
6,000 Added 17.65%
39,997 $800,000
Q4 2020

Jan 25, 2021
BUY
$15.77 - $19.03 $85,426 - $103,085
5,417 Added 18.95%
33,997 $578,000
Q3 2020

Oct 20, 2020
SELL
$16.59 - $24.79 $151,566 - $226,481
-9,136 Reduced 24.22%
28,580 $474,000
Q2 2020

Jul 27, 2020
BUY
$16.86 - $23.44 $291,728 - $405,582
17,303 Added 84.76%
37,716 $874,000
Q1 2020

Apr 17, 2020
BUY
$14.47 - $27.96 $131,677 - $254,436
9,100 Added 80.44%
20,413 $364,000
Q4 2019

Jan 17, 2020
BUY
$15.87 - $23.12 $26,074 - $37,986
1,643 Added 16.99%
11,313 $244,000
Q3 2019

Oct 17, 2019
SELL
$16.91 - $36.27 $957,613 - $2.05 Million
-56,630 Reduced 85.41%
9,670 $176,000
Q2 2019

Jul 12, 2019
BUY
$31.0 - $36.3 $453,902 - $531,504
14,642 Added 28.34%
66,300 $2.36 Million
Q1 2019

Apr 17, 2019
BUY
$31.58 - $46.35 $1.04 Million - $1.53 Million
32,989 Added 176.7%
51,658 $1.74 Million
Q4 2018

Jan 17, 2019
SELL
$30.43 - $56.65 $1.19 Million - $2.22 Million
-39,255 Reduced 67.77%
18,669 $614,000
Q3 2018

Oct 16, 2018
BUY
$46.46 - $68.49 $2.27 Million - $3.35 Million
48,924 Added 543.6%
57,924 $3.53 Million
Q2 2018

Jul 19, 2018
SELL
$46.25 - $104.45 $888,000 - $2.01 Million
-19,200 Reduced 68.09%
9,000 $439,000
Q1 2018

Apr 10, 2018
BUY
$57.4 - $108.44 $1.57 Million - $2.97 Million
27,350 Added 3217.65%
28,200 $3 Million
Q3 2017

Oct 13, 2017
BUY
$17.79 - $24.0 $15,121 - $20,400
850
850 $20,000

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $193M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email